Influence of Attention-Deficit/Hyperactivity Disorder Symptoms on Methadone Treatment Outcome
Article first published online: 18 FEB 2010
DOI: 10.1080/10601330601080073
2007 American Academy of Addiction Psychiatry
Additional Information
How to Cite
Kolpe, M. and Carlson, G. A. (2007), Influence of Attention-Deficit/Hyperactivity Disorder Symptoms on Methadone Treatment Outcome. The American Journal on Addictions, 16: 46–48. doi: 10.1080/10601330601080073
Publication History
- Issue published online: 18 FEB 2010
- Article first published online: 18 FEB 2010
- Received November 10, 2005; revised December 14, 2005; accepted January 30, 2006.
- Abstract
- Article
- References
- Cited By
A review of 687 consecutive admissions to a Midwestern methadone maintenance program was undertaken to establish the prevalence of ADHD symptoms and their association with treatment outcome. Of the 687 admissions, 396 (58%) patients self-reported experiencing one or more ADHD symptoms during the two weeks prior to admission, and 131 (19%) patients reported ADHD symptoms that significantly interfered with functioning in daily activities. At nine months post-admission, the patients who reported significant symptoms of ADHD were able to reduce their drug use but were less likely to have achieved abstinence than those who did not report significant symptoms (p ≤ 0.001). The authors discuss the importance of screening for ADHD symptoms in methadone treatment programs and propose interventions believed helpful in improving management of ADHD symptoms and improving outcome.

1521-0391/asset/olbannercenter.gif?v=1&s=6284b6b79aa75cd023e0315611e29ae611aeafe6)
1521-0391/asset/cover.gif?v=1&s=3f5974d37153004560c8fd0bdfda4cecff3cad59)